Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects

Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects

Leishmaniasis is a zoonotic disease transmitted in humans by the bite of <i>Leishmania</i>-infected phlebotomine sandflies. Each year approximately 58,500 cases of leishmaniasis are diagnosed across the globe, with a mortality rate of nearly seven percent. There are over 20 parasitic str...

Full description

Bibliographic Details
Main Authors: Ali A. Rabaan, Muhammed A. Bakhrebah, Ranjan K. Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Al-Najjar, Mona A. Alhusayyen, Ghadeer H. Al-Absi, Yahya Aldawood, Abdulmonem A. Alsaleh, Saleh A. Alshamrani, Souad A. Almuthree, Abdulsalam Alawfi, Amer Alshengeti, Ameen S. S. Alwashmi, Khalid Hajissa, Majed S. Nassar
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pathogens
Subjects:
leishmaniasis
proteomics
structural proteomics
target proteins
drug discovery
Online Access:https://www.mdpi.com/2076-0817/12/1/39

Similar Items

Similar Items